Eternity Healthcare Inc. announced that it has signed an agreement with Shanghai Yin Jun Investment & Development Inc., to establish a Joint Venture manufacturing operation in China. Shanghai Yin Jun will invest initially $3 million dollars into the Joint Venture company. Eternity Healthcare, Inc. will be responsible for clinical trials, regulatory approval and marketing of the product worldwide.

The JV Company will manufacture certain medical devices that have mass marketing appeal, with the possibility of having several million dollars in sales annually. After covering all the expenses, including manufacturing, promotion and marketing payments by the JV Company, the remaining profit will be divided equally between Eternity Healthcare, Inc. and Shanghai Yin Jun Investment group. Shanghai Yin Jun Investment group has the option to convert their 50% holding in the JV Company into Eternity Healthcare, Inc. stock for 4 million Common shares within the next 30 months at the price of $0.75 per share.

Once this happens, Eternity Healthcare, Inc. will then own 100% of the JV Company.